SunWay Biotech Co., LTD. (TPEX:1271)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
57.50
+0.50 (0.88%)
Apr 28, 2026, 12:50 PM CST
-8.87%
Market Cap 3.47B
Revenue (ttm) 951.52M
Net Income (ttm) 84.86M
Shares Out 60.39M
EPS (ttm) 1.40
PE Ratio 41.07
Forward PE n/a
Dividend 1.33 (2.33%)
Ex-Dividend Date Jul 16, 2025
Volume 46,362
Average Volume 118,739
Open 57.00
Previous Close 57.00
Day's Range 56.50 - 58.90
52-Week Range 51.00 - 90.80
Beta -0.22
RSI 46.07
Earnings Date Apr 30, 2026

About SunWay Biotech Co., LTD.

SunWay Biotech Co., LTD. focuses on professional research and development, and technical material manufacturing and processing business. The company offers red yeast rice and lactic acid bacteria products, as well as other health supplements; and wholesale and manufacturing of pharmaceutical products. The company also researches, designs, and manufactures Monascus purpureus NTU 568; Lactobacillus paracasei subsp. paracasei NTU 101; and related products. The company was founded in 2007 and is based in Taipei, Taiwan. [Read more]

Industry Packaged Foods
Founded 2007
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 1271
Full Company Profile

Financial Performance

In 2024, SunWay Biotech Co., LTD.'s revenue was 970.18 million, an increase of 69.88% compared to the previous year's 571.11 million. Earnings were 118.57 million, an increase of 157.26%.

Financial Statements

News

There is no news available yet.